Coastlands Capital LP
Transaction: 06/17/2026
BUY
Change
+100,000
Price
$0.53
Filing
06/22/2026
Type
BUY
Pasithea Therapeutics Corp.
KTTA • Biotechnology
$0.41
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$13.16M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 11.35Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.41
Change0.00%
Shares Out32.10M
Market Cap$13.16M
Enterprise Value$-45.65B
52W Range0.28 - 2.06
Beta0.29
P/E-0.00
P/B0.00
P/FCF-0.00
EV/EBITDA7.97
EV/FCF4.80
Price$0.41
Change0.00%
Shares Out32.10M
Market Cap$13.16M
Enterprise Value$-45.65B
52W Range0.28 - 2.06
Beta0.29
P/E-0.00
P/B0.00
P/FCF-0.00
EV/EBITDA7.97
EV/FCF4.80
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio11.35
Quick Ratio11.35
Target$3.00
Target Upside631.71%
Target Median$3.00
Target Range3.00 - 3.00
Volume39.65K
Avg Volume691.57K
EPS Surprise0.33
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 11.35Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-20
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Price Target
2026-08-16
Low
$3.00
Mean
$3.00
Median
$3.00
High
$3.00
Insider Transactions
Recent executive and insider activity
Krishnan Kartik
Transaction: 05/01/2026
OTHER
Change
0
Price
Not reported
Filing
05/05/2026
Type
OTHER
Novak Alfred J
Transaction: 05/01/2026
BUY
Change
+152,783
Price
$0.84
Filing
05/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Coastlands Capital LP | BUY | +100,000 | $0.53 | 06/17/2026 | 06/22/2026 |
| Krishnan Kartik | OTHER | 0 | Not reported | 05/01/2026 | 05/05/2026 |
| Novak Alfred J | BUY | +152,783 | $0.84 | 05/01/2026 | 05/05/2026 |
| Leahy Emer | BUY | +152,783 | $0.84 | 05/01/2026 | 05/05/2026 |
| Krishnan Kartik | BUY | +1,129,323 | $0.84 | 05/01/2026 | 05/05/2026 |
| Schneiderman Daniel H | BUY | +1,129,323 | $0.84 | 05/01/2026 | 05/05/2026 |
| Dumesnil Simon | BUY | +152,783 | $0.84 | 05/01/2026 | 05/05/2026 |
| STEINMAN LAWRENCE | BUY | +152,783 | $0.84 | 05/01/2026 | 05/05/2026 |
| Marques Tiago | BUY | +1,756,069 | $0.84 | 05/01/2026 | 05/05/2026 |
| Coastlands Capital LP | OTHER | +11,233,334 | $0.00 | 04/09/2026 | 04/17/2026 |
| Coastlands Capital LP | OTHER | 0 | Not reported | 04/09/2026 | 04/17/2026 |
| Leahy Emer | BUY | +33,333 | $0.75 | 11/28/2025 | 12/01/2025 |
| Dumesnil Simon | BUY | +33,333 | $0.75 | 11/28/2025 | 12/01/2025 |
| Marques Tiago | BUY | +33,333 | $0.75 | 11/28/2025 | 12/01/2025 |
| Schneiderman Daniel H | BUY | +26,667 | $0.75 | 11/28/2025 | 12/01/2025 |
| STEINMAN LAWRENCE | BUY | +133,333 | $0.75 | 11/28/2025 | 12/01/2025 |
| Dumesnil Simon | BUY | +42,913 | $0.71 | 10/24/2025 | 10/27/2025 |
| Leahy Emer | BUY | +42,913 | $0.71 | 10/24/2025 | 10/27/2025 |
| Marques Tiago | BUY | +493,341 | $0.71 | 10/24/2025 | 10/27/2025 |
| Novak Alfred J | BUY | +42,913 | $0.71 | 10/24/2025 | 10/27/2025 |